Free Trial

Sanofi (SNY) News Today

Sanofi logo
$54.04 +1.89 (+3.61%)
As of 12:31 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Sanofi board proposed dividend of EUR 3.92 for FY24
Sanofi expects earliest closing of Opella stake in Q2
Sanofi reports Q4 IRFS EPS EUR 0.54
Sanofi expects FY25 business EPS growth at LDD percentage at CER
Sanofi stock logo
Analysts Set Expectations for Sanofi FY2024 Earnings
Sanofi (NASDAQ:SNY - Free Report) - Equities researchers at Leerink Partnrs issued their FY2024 earnings estimates for Sanofi in a report issued on Monday, January 27th. Leerink Partnrs analyst D. Risinger forecasts that the company will post earnings per share of $3.77 for the year. The consensu
Sanofi Q4 Business Net Income Declines; Net Sales Up 10.3% At CER
Sanofi stock logo
Manning & Napier Advisors LLC Boosts Position in Sanofi (NASDAQ:SNY)
Manning & Napier Advisors LLC raised its stake in Sanofi (NASDAQ:SNY - Free Report) by 4.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 280,881 shares of the company's stock after purchasing an additional 12,688
Time To Be Bullish On Sanofi Ahead Of Its Earnings
Sanofi stock logo
Q3 Earnings Estimate for Sanofi Issued By Leerink Partnrs
Sanofi (NASDAQ:SNY - Free Report) - Investment analysts at Leerink Partnrs issued their Q3 2025 earnings per share (EPS) estimates for shares of Sanofi in a report issued on Monday, January 27th. Leerink Partnrs analyst D. Risinger expects that the company will post earnings of $1.57 per share fo
Investors Buy Large Volume of Sanofi Put Options (NASDAQ:SNY)
Sanofi (SNY) Expected to Announce Earnings on Thursday
Sanofi stock logo
Sanofi (SNY) Projected to Post Earnings on Thursday
Sanofi (NASDAQ:SNY) will be releasing earnings before the market opens on Thursday, January 30, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=548546)
Sanofi stock logo
Zacks Research Has Positive Outlook for Sanofi Q1 Earnings
Sanofi (NASDAQ:SNY - Free Report) - Investment analysts at Zacks Research lifted their Q1 2025 EPS estimates for Sanofi in a research note issued to investors on Wednesday, January 22nd. Zacks Research analyst K. Shah now expects that the company will post earnings of $0.85 per share for the quar
Sanofi stock logo
Sanofi Target of Unusually High Options Trading (NASDAQ:SNY)
Sanofi (NASDAQ:SNY - Get Free Report) was the recipient of unusually large options trading on Monday. Traders acquired 2,013 put options on the stock. This represents an increase of approximately 68% compared to the typical volume of 1,201 put options.
Equities Analysts Offer Predictions for Sanofi Q1 Earnings
Sanofi stock logo
Zacks Research Analysts Boost Earnings Estimates for Sanofi
Sanofi (NASDAQ:SNY - Free Report) - Stock analysts at Zacks Research increased their Q1 2025 earnings per share estimates for Sanofi in a research report issued on Wednesday, January 22nd. Zacks Research analyst K. Shah now anticipates that the company will post earnings per share of $0.85 for th
Sanofi stock logo
Janney Montgomery Scott LLC Increases Stock Holdings in Sanofi (NASDAQ:SNY)
Janney Montgomery Scott LLC increased its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 5.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 327,631 shares of the company's stock after purchasing an additional 1
Zacks Research Predicts Sanofi's Q3 Earnings (NASDAQ:SNY)
Sanofi stock logo
Sound Income Strategies LLC Raises Position in Sanofi (NASDAQ:SNY)
Sound Income Strategies LLC grew its position in shares of Sanofi (NASDAQ:SNY - Free Report) by 156,520.9% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 67,347 shares of the company's stock after acquiring an additional 67,304 shares during the period.
Sanofi stock logo
Zacks Research Comments on Sanofi's Q3 Earnings (NASDAQ:SNY)
Sanofi (NASDAQ:SNY - Free Report) - Zacks Research raised their Q3 2025 earnings estimates for Sanofi in a research note issued on Wednesday, January 22nd. Zacks Research analyst K. Shah now anticipates that the company will post earnings per share of $1.59 for the quarter, up from their prior fo
Sanofi stock logo
Baker Ellis Asset Management LLC Sells 5,281 Shares of Sanofi (NASDAQ:SNY)
Baker Ellis Asset Management LLC lessened its stake in shares of Sanofi (NASDAQ:SNY - Free Report) by 5.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 86,908 shares of the company's stock after selling 5,281 shares du
Sanofi stock logo
Sanofi (SNY) Expected to Announce Quarterly Earnings on Thursday
Sanofi (NASDAQ:SNY) will be releasing earnings before the market opens on Thursday, January 30, Financial Modeling Prep reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=548546)
Sanofi’s Framingham facility hit with FDA warning
Sanofi stock logo
HB Wealth Management LLC Grows Position in Sanofi (NASDAQ:SNY)
HB Wealth Management LLC grew its stake in Sanofi (NASDAQ:SNY - Free Report) by 151.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 15,496 shares of the company's stock after acquiring an additi
Press Release: Opella reaches study milestone for Cialis
Sanofi stock logo
Ritholtz Wealth Management Decreases Stake in Sanofi (NASDAQ:SNY)
Ritholtz Wealth Management reduced its stake in Sanofi (NASDAQ:SNY - Free Report) by 17.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 42,559 shares of the company's stock after selling 8,692 shares during the peri
Sanofi stock logo
Sanofi (NASDAQ:SNY) Shares Bought by Park Avenue Securities LLC
Park Avenue Securities LLC increased its holdings in Sanofi (NASDAQ:SNY - Free Report) by 14.3% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 68,982 shares of the company's stock after acquiring an additional 8,615 sha
Sanofi stock logo
Pines Wealth Management LLC Invests $247,000 in Sanofi (NASDAQ:SNY)
Pines Wealth Management LLC bought a new stake in shares of Sanofi (NASDAQ:SNY - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 5,072 shares of the company's stock, valued at
IGM Biosciences price target lowered to $2 from $12 at Truist
Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.

SNY Media Mentions By Week

SNY Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

SNY
News Sentiment

0.88

0.76

Average
Medical
News Sentiment

SNY News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

SNY Articles
This Week

41

13

SNY Articles
Average Week

Get Sanofi News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNY and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:SNY) was last updated on 1/30/2025 by MarketBeat.com Staff
From Our Partners